Merck Kgaa-Sponsored ADRMKKGY
13F holders, Q2 2026 (June 30)5holders −4
1new positions
5sold out
$32.31avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Merck Kgaa-Sponsored ADR (MKKGY) in their 13F filings, down 4 from Q1 2026. 1 opened new positions and 5 sold out. The largest holders were Rhumbline Advisers ($367K), GAMMA Investing LLC ($77K) and Atlas Capital Advisors Inc. ($62K).
- Company
- Merck Kgaa-Sponsored ADR
- CUSIP
- 589339209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $62K |
| Exits | 5 | $1.5M |
All 13F filers, Q1 2026 → Q2 2026: 3,258 shares bought and 61,997 shares sold, net −58,739 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Rhumbline Advisers | 0.00% | Reduce -0.3% | 10,919 | $367K |
| GAMMA Investing LLC | 0.00% | Add +35.3% | 2,302 | $77K |
| Atlas Capital Advisors Inc. | 0.01% | New | 2,467 | $62K |
| Salomon & Ludwin, LLC | 0.00% | Add +114.5% | 356 | $12K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -99.0% | 2 | $67 |
"% of holder's portfolio" is MKKGY's weight in each manager's 13F, not the share of Merck Kgaa-Sponsored ADR the manager owns.